Get started
ATOS: Selling rallies as lower prices are expectedATOS - Intraday - We look to Sell at 38.73 (stop at 41.72) The medium term bias remains bearish. Trading within a Bearish Channel formation. A move lower has resulted in prices breaking from the previous range and confirmed our bearish expectation. The formation has a measured move target of 30.61. Further downside is expected although we prefer to set shorts at our bespoke resistance levels at 38.73, resulting in improved risk/reward. Our profit targets will be 30.60 and 28.00 Resistance: 38.74 / 41.13 / 47.16 Support: 36.40 / 36.00 / 34.62 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
EURONEXT:ATOShort
by Saxo
KBC.BR has upside potential in 2022 but long term uncertainOff the covid crash low we were 3 waves up before a correction began, currently retrace to around 0.786 fib. As long as 60 (the 0.5 fib) hold, I can see upside target 1.382 fib, which is ...surprise surprise... right at the ATH... struck in 2008 just before the GFC crash... All coincident aside, after 5 waves completion, a bigger degree of correction will occur, the bullish portion of this cycle is probably at its exhaustion. Fundamentally, KBC is one of the best capitalized banks in continental Europe, can outperform its peers. The caveat: Financials have been systematically underperforming the market sinds the GFC.
EURONEXT:KBC
by EuroStockOption
SocGen (GLE.pa) bullish scenario:The technical figure Triangle can be found in the French company Société Générale S.A. (GLE.pa) at daily chart. Société Générale S.A., often nicknamed "SocGen", is a multinational investment bank and financial services company. The company is a universal bank and has divisions supporting French Networks, Global Transaction Banking, International Retail Banking, Financial Services, Corporate and Investment Banking, Private Banking, Asset Management and Securities Services. The Triangle has broken through the resistance line on 23/12/2021, if the price holds above this level you can have a possible bullish price movement with a forecast for the next 12 days towards 31.065 EUR. Your stop loss order according to experts should be placed at 27.770 EUR if you decide to enter this position. The U.S. Department of Justice on Tuesday ended a criminal case against Societe Generale SA related to violations of U.S. sanctions, after the French bank agreed to pay $1.34 billion and met the terms of a three-year deferred prosecution agreement. Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
EURONEXT:GLELong
by legacyFXofficial
Novacyt ALNOV Graham Mullis, CEO of the Novacyt Group, commented: “Novacyt continues to process COVID-19 tests for current and future demand. We continue to ensure that innovation is at the center of our strategy and that our growing portfolio of COVID-19 tests is available to clients in private and public healthcare facilities to expand existing partnerships and support new partnerships. Throughout the pandemic, the demand for NHS testing has remained a key priority for the company and the award of the contract under the National PHE Microbiology Framework is a testament to our continued commitment. “We believe that our long-term strategy also supports the growth of Novacyt after COVID-19. In particular, our progress and growth potential in the private sector will not only help us maximize the opportunity for COVID-19 testing, but also ensure that we are well positioned, along with technologies and partners, for sustainable growth. beyond COVID-19. We therefore believe that Novacyt is well placed to continue to develop its business transformation. " This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014. About the Novacyt Group The Novacyt Group is an international diagnostic company generating a growing portfolio of in vitro and molecular diagnostic tests. Its main strengths lie in the development, marketing, design and manufacture of diagnostic products. The main business units of the Company include the Primerdesign and Lab21 products, providing a wide range of high quality assays and reagents worldwide. The Group directly serves the microbiology, hematology and serology markets as well as its global partners, including large companies.
EURONEXT:ALNOVLong
by wallstreetstocks
Trading Idea - #Airbus Seasonality Trading#Airbus Seasonality Trading! BUY ENTRY: 104.25 EUR TARGET: 109.38 EUR STOP: 101.04 EUR I checked the Seasonality for the 20.Dec to the 13. Jan timeframe over the last 15 years! According to historical data, we have a bullish phase ahead with a probability of 90%. The average gain over the last 15 years in this time frame was 4.5%. My target for the current period is 5%. Besides this, we see a short-term ascending support line!
EURONEXT:AIRLong
by Traderherz-Analytics
Risky position but promising in the long termDear long-term investor, welcome to this new analysis of Ubisoft. Despite a massive disappointment from gamers towards Ubisoft's games EURONEXT:UBI , accused of preferring numbers to quality, Ubisoft has announced that they want to get closer to their community, which could announce better games in the future? A few days ago, they announced a potential remaster of Splinter Cell, a nostalgic license for many people, this announcement was rather well received by the majority despite a number of players worried about seeing this game "destroyed". From an analytical point of view, a large majority of indicators point to a potential upside, but the market sentiment is rather bad, which could herald a drop to 36.71. It's hard to guess the market in the short term, but with Ubisoft's numerous announcements, we're pretty bullish in the long term on the company's future. But feel free to do your own research, this is just an analysis, this scenario may not come true. This is not an investment advice. Here are the scenarios I can share with you: A possibility of making a w chartist figure on the 39,64 level, followed by a massive climb, perhaps to the 57,2 or higher. A possibility to break the 39.64 to consolidate towards the 36.71, then go back up. An unlikely possibility of breaking even lower than 36,71.
EURONEXT:UBILong
by Absconse
Just Eat Takeaway: Selling a retest of pandemic lows Just Eat Takeaway - Short Term - We look to Sell at 58.56 (stop at 66.36) We look to sell rallies. Previous support at 59.00 now becomes resistance. The trend of lower highs is located at 66.36. We look for a temporary move higher. The bias is still for lower levels and we look for any gains to be limited. Further downside is expected although we prefer to set shorts at our bespoke resistance levels at 59.00, resulting in improved risk/reward. Our profit targets will be 41.07 and 36.80 Resistance: 59.00 / 72.50 / 83.00 Support: 47.37 / 42.69 / 36.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
EURONEXT:TKWYShort
by Saxo